August 20, 2009
Kuraray Medical Inc.
Kuraray Medical Inc. (a wholly owned subsidiary of Kuraray Co., Ltd., Head Office: Chiyoda-ku, Tokyo) announces that it has obtained approval under the Pharmaceutical Affairs Law to manufacture and market its artificial bone graft medical devices.
A artificial bone graft is a product used for medical treatment should a bone transplant become necessary as a result of disease or injury. There are three types of bone transplants:
At present, autologous bone grafts are the predominant type of bone transplant in Japan. However, this requires healthy bone to be cut away from the patient's own body. Kuraray Medical thus aimed to develop the third type, a artificial bone graft that could replace autologous bone grafts.
Kuraray Medical developed the new bone grafts in collaboration with the Ceramic Biomaterial Group, Biomaterials Center, National Institute for Materials Science and the Department of Orthopedics, Institute of Clinical Medicine, The University of Tsukuba. Made of hydroxylapatite, the chief component of living bone, the aligned connectivity and porous structure of this product are conducive to binding together with surrounding bone and supplementing bone growth into the internal portion of the graft.
This product will be available nationwide following limited sales at selected medical facilities. Kuraray Medical is positioning this product as a cornerstone of its efforts to develop the artificial bone graft market.
|Classification||High-level controlled medical device (Class Ⅲ)|
|General name||Artificial bone graft|
|Manufacturing and sales||Kuraray Medical Inc.|
|Type||Configured product (cubic, cylindrical, spacer type), granular|
|Head office||Ote Center Building, 1-1-3, Otemachi, Chiyoda-ku, Tokyo|
|Paid-in capital||¥300 million (100% owned by Kuraray Co., Ltd.)|
|Business activities||Manufacturing, development and sales of medical-related products|